Postoperative Chewing Gum and Gynecological Laparoscopic Surgery
|ClinicalTrials.gov Identifier: NCT03884244|
Recruitment Status : Completed
First Posted : March 21, 2019
Last Update Posted : March 21, 2019
|Condition or disease||Intervention/treatment||Phase|
|Gynecologic Disease Postoperative Ileus Paralytic Ileus||Other: chewing gum||Not Applicable|
The team of the research team of the research team will listen and record the bowel sounds of the patients, using a stethoscope every two hours starting from the postoperative 3rd hour until the first bowel sounds are heard in each patient.
Patients who were able to tolerate patients starting from the 8th hour after the surgery were allowed for mobilization. Also, they were allowed to take fluid regimen from the postoperative 12th hour. Patient satisfaction was evaluated by using visual analogue scale (VAS) on the day of discharge on chewing postoperative.
The primary index for the return of GI functions was the first gas removal time. Secondary index was the time of first bowel sound, the first time of admission, hospitalization time and the presence of postoperative ileus.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||200 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Supportive Care|
|Official Title:||The Effect of Postoperative Chewing Gum on Intestinal Functions After Gynecological Laparoscopic Surgery|
|Actual Study Start Date :||March 1, 2018|
|Actual Primary Completion Date :||March 1, 2019|
|Actual Study Completion Date :||March 1, 2019|
|Active Comparator: taking chewing gum patients||
Other: chewing gum
The group who take chewing gum after operation
|No Intervention: no chewing gum|
- Postoperative Bowel Functions [ Time Frame: Postoperative first 1440 minutes ]The Effect of Postoperative Chewing Gum on Intestinal Functions after Gynecological Laparoscopic Surgery ; The primary index for the return of GI functions was the first gas removal time. Patient first extraction of gas, recorded in minutes.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03884244
|Istanbul, Turkey, 33403|